Shares of Cabot Corp (NYSE:CBT) have been given a consensus rating of “Hold” by the nine analysts that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year target price among brokers that have covered the stock in the last year is $46.71.

CBT has been the topic of several research analyst reports. UBS Group upgraded shares of Cabot from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $50.00 to $52.00 in a research note on Friday, February 7th. Zacks Investment Research downgraded shares of Cabot from a “hold” rating to a “sell” rating and set a $47.00 price objective on the stock. in a research note on Friday, October 25th. Barclays restated a “buy” rating and issued a $52.00 price objective on shares of Cabot in a research note on Wednesday, February 5th. ValuEngine downgraded shares of Cabot from a “hold” rating to a “sell” rating in a research note on Thursday, February 6th. Finally, JPMorgan Chase & Co. downgraded shares of Cabot from an “overweight” rating to a “neutral” rating and raised their price objective for the stock from $40.00 to $45.00 in a research note on Wednesday, November 6th. They noted that the move was a valuation call.

Shares of Cabot stock traded up $0.31 during midday trading on Friday, hitting $43.45. The company had a trading volume of 397,900 shares, compared to its average volume of 313,739. The business’s 50 day simple moving average is $44.14 and its two-hundred day simple moving average is $44.37. The stock has a market cap of $2.45 billion, a PE ratio of 19.84, a P/E/G ratio of 1.51 and a beta of 1.59. The company has a debt-to-equity ratio of 0.95, a current ratio of 2.08 and a quick ratio of 1.25. Cabot has a 1-year low of $37.11 and a 1-year high of $50.58.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $0.69 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.04). The company had revenue of $727.00 million during the quarter, compared to analyst estimates of $772.38 million. Cabot had a return on equity of 18.47% and a net margin of 3.98%. The company’s revenue was down 11.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.87 EPS. On average, sell-side analysts expect that Cabot will post 3.68 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 28th will be given a $0.35 dividend. The ex-dividend date is Thursday, February 27th. This represents a $1.40 annualized dividend and a yield of 3.22%. Cabot’s dividend payout ratio (DPR) is currently 35.81%.

In related news, SVP Hobart Kalkstein sold 2,833 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $48.34, for a total value of $136,947.22. Following the completion of the transaction, the senior vice president now directly owns 40,954 shares of the company’s stock, valued at $1,979,716.36. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.08% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of CBT. Evoke Wealth LLC bought a new position in shares of Cabot during the third quarter valued at $28,000. First Bank & Trust lifted its holdings in shares of Cabot by 463.9% during the fourth quarter. First Bank & Trust now owns 1,156 shares of the specialty chemicals company’s stock valued at $55,000 after acquiring an additional 951 shares during the period. Chevy Chase Trust Holdings Inc. bought a new position in shares of Cabot during the fourth quarter valued at $60,000. Ladenburg Thalmann Financial Services Inc. lifted its holdings in shares of Cabot by 81.3% during the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,960 shares of the specialty chemicals company’s stock valued at $94,000 after acquiring an additional 879 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new position in shares of Cabot during the fourth quarter valued at $202,000. 85.99% of the stock is owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.

Further Reading: What does cost of debt say about a company’s financial health?

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.